Average Co-Inventor Count = 5.41
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sigma-tau Industrie Farmaceutiche Riunite S.p.a. (8 from 343 patents)
2. Biogem S.c. a R.l. (3 from 3 patents)
3. Istituto Nazionale Per Lo Studio E La Cura Dei Tumori (1 from 14 patents)
4. Fondazione Irccs “Instituto Nazionale Dei Tumori” (1 from 3 patents)
5. Instituto Nazionale Per Lo Studio E La Cura Dei Tumori (1 from 3 patents)
6. Istituo Nazionale Per Lo Studio E La Cura Dei Tumori (1 from 1 patent)
12 patents:
1. 11819484 - Retinoid derivatives with antitumor activity
2. 11364216 - Retinoid derivatives with antitumor activity
3. 10905668 - Retinoid derivatives with antitumor activity
4. 10093621 - 4-oxo-N-(4-hydroxyphenyl)retinamide derivatives as therapeutic agents for the treatment of cancer
5. 8530517 - Retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties
6. 8101793 - Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities
7. 7728039 - Biphenyl and Naphthyl-Phenyl Hydroxamic Acid Derivatives
8. 7705012 - Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents
9. 7589099 - 7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists
10. 7449495 - Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities
11. 7351714 - 7-imino derivatives of camptothecin having antitumor activity
12. 7105492 - Camptothecin derivatives having antitumor activity